← Back to patent-cliff list
CAS 116313-85-0
3,4-dihydroxy-5-nitrobenzaldehyde
Codes: ENTA-001
Application context (from source-drug indications)
Parkinson's diseaseEntacapone立位耐力不良EntacaponeTachycardiaEntacaponeObesityEntacapone
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Entacapone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3,4-dihydroxy-5-nitrobenzaldehyde→2-cyanoacetic acid→(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylic acid→(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acryloyl chloride→diethylamine
3,4-dihydroxy-5-nitrobenzaldehyde→2-cyano-N,N-diethylacetamide→2-cyanoacetic acid→4-hydroxy-3-methoxy-5-nitrobenzaldehyde
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.